Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Smooth Endoplasmic Reticulum

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study.

Clinical ophthalmology (Auckland, N.Z.)·2012

Same author

Unilateral retinitis pigmentosa and cone-rod dystrophy.

Clinical ophthalmology (Auckland, N.Z.)·2009

Same author

Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy.

Archives of ophthalmology (Chicago, Ill. : 1960)·2009

Same author

Individual variation in human motor-sensory (rolandic) cortex.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2007

Same author

Study of the human visual cortex: direct cortical evoked potentials and stimulation.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2007

Search research articles

Related Experiment Video

Updated: May 17, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Neonatal adrenoleukodystrophy: a clinical, pathologic, and biochemical study.

Donald F Farrell¹

¹Neurology Department at School of Medicine, University of Washington, Seattle, Washington, USA. donf@u.washington.edu

Pediatric Neurology

|October 10, 2012

Summary

Neonatal adrenoleukodystrophy is a genetic disorder characterized by severe infant symptoms and distinct lipid storage. Its unique brain lipid profile, particularly elevated vinyl ether plasmalogens, differentiates it from Zellweger syndrome.

More Related Videos

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Related Experiment Videos

Last Updated: May 17, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Area of Science:

Biochemistry
Genetics
Neonatal Medicine

Background:

Neonatal adrenoleukodystrophy (NALD) is an autosomal recessive genetic disorder.
NALD shares very long chain fatty acid (VLCFA) storage with Zellweger syndrome and X-linked adrenoleukodystrophy but is clinically and biochemically distinct.
Clinical features of NALD include hypotonia, psychomotor retardation, failure to thrive, blindness, deafness, and seizures, often present at birth.

Observation:

Infants with NALD exhibit a characteristic retinopathic "leopard spot" pattern.
Biochemical analysis of brains from NALD infants revealed abnormal complex lipid profiles.
Specific analyses focused on very long chain fatty acids (VLCFAs) and brain plasmalogens.

Findings:

NALD brains showed accumulation of VLCFAs, particularly in cholesterol esters.
Marked elevation of vinyl ether ethanolamine plasmalogens was identified in NALD brains.
The presence of stored vinyl ether plasmalogens distinguishes NALD from Zellweger syndrome, which cannot synthesize plasmalogens.

Implications:

The distinct lipid storage pattern, especially elevated vinyl ether plasmalogens, serves as a key diagnostic marker for NALD.
Understanding these biochemical differences aids in differentiating NALD from other leukodystrophies.
This research contributes to the understanding of lipid metabolism disorders in neonates.